| Year |
Citation |
Score |
| 2012 |
Xu D, Kim Y, Postelnek J, Vu MD, Hu DQ, Liao C, Bradshaw M, Hsu J, Zhang J, Pashine A, Srinivasan D, Woods J, Levin A, O'Mahony A, Owens TD, et al. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. The Journal of Pharmacology and Experimental Therapeutics. 341: 90-103. PMID 22228807 DOI: 10.1124/Jpet.111.187740 |
0.344 |
|
| 2002 |
Fujino H, Srinivasan D, Regan JW. Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptor. The Journal of Biological Chemistry. 277: 48786-95. PMID 12368277 DOI: 10.1074/Jbc.M209393200 |
0.528 |
|
| 2002 |
Srinivasan D, Fujino H, Regan JW. Differential internalization of the prostaglandin f(2alpha) receptor isoforms: role of protein kinase C and clathrin. The Journal of Pharmacology and Experimental Therapeutics. 302: 219-24. PMID 12065720 DOI: 10.1124/Jpet.302.1.219 |
0.607 |
|
| 2000 |
Fujino H, Pierce KL, Srinivasan D, Protzman CE, Krauss AH, Woodward DF, Regan JW. Delayed reversal of shape change in cells expressing FP(B) prostanoid receptors. Possible role of receptor resensitization. The Journal of Biological Chemistry. 275: 29907-14. PMID 10893233 DOI: 10.1074/Jbc.M003467200 |
0.611 |
|
| 2000 |
Fujino H, Srinivasan D, Pierce KL, Regan JW. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C. Molecular Pharmacology. 57: 353-8. PMID 10648645 |
0.593 |
|
| 1999 |
Pierce KL, Fujino H, Srinivasan D, Regan JW. Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton. The Journal of Biological Chemistry. 274: 35944-9. PMID 10585482 DOI: 10.1074/Jbc.274.50.35944 |
0.603 |
|
| Show low-probability matches. |